Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 44.89B | 57.94B | 70.72B | 75.26B | 83.81B | 65.76B |
Gross Profit | 8.95B | 11.44B | 12.05B | 13.61B | 13.31B | 16.70B |
EBITDA | 4.08B | 9.51B | 11.36B | 37.38B | 29.69B | 4.55B |
Net Income | 5.80B | 4.49B | 7.09B | 27.54B | 20.92B | -1.79B |
Balance Sheet | ||||||
Total Assets | 202.81B | 126.61B | 89.02B | 89.84B | 74.63B | 72.35B |
Cash, Cash Equivalents and Short-Term Investments | 14.74B | 28.06B | 20.72B | 25.77B | 21.41B | 17.26B |
Total Debt | 6.00B | 0.00 | 0.00 | 0.00 | 4.79B | 28.49B |
Total Liabilities | 51.30B | 23.94B | 14.49B | 22.41B | 24.58B | 41.32B |
Stockholders Equity | 151.17B | 102.41B | 74.54B | 67.43B | 50.04B | 28.19B |
Cash Flow | ||||||
Free Cash Flow | -7.30B | 7.05B | 295.32M | -1.48B | 4.49B | 26.62B |
Operating Cash Flow | -4.83B | 8.16B | 1.24B | -195.28M | 5.51B | 28.26B |
Investing Cash Flow | 3.05B | 214.06M | -5.52B | 20.02B | 17.02B | -2.54B |
Financing Cash Flow | -2.08B | -5.39B | -1.74B | -16.53B | -18.81B | -18.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥18.46T | 30.18 | 10.50% | 1.09% | 0.56% | 5.36% | |
77 Outperform | ¥5.16T | 28.88 | 8.97% | 0.74% | -1.55% | 17.21% | |
75 Outperform | ¥3.38T | 9.23 | 7.85% | 2.76% | -0.45% | -17.53% | |
73 Outperform | $22.00T | 19.08 | 14.32% | 0.56% | -0.49% | 19.71% | |
73 Outperform | $3.43T | 20.91 | 7.22% | 1.45% | -10.70% | -47.63% | |
69 Neutral | ¥229.01B | 14.09 | 7.50% | 2.69% | 9.25% | 8.21% | |
68 Neutral | ¥92.31B | 16.88 | 4.83% | 1.16% | -27.90% | 35.64% |